ADC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	231.01	261.34	250.87	278.6	326.44	466.54
Cash & Short-Term Investments	231.01	261.34	250.87	278.6	326.44	466.54
Cash Growth	18.65%	4.17%	-9.95%	-14.66%	-30.03%	6.23%
Accounts Receivable	31.05	29.12	20.32	25.18	72.97	30.22
Inventory	4.78	4.18	2.25	16.18	18.56	11.12
Other Current Assets	9.94	11.7	17.82	16.33	28.04	17.3
Total Current Assets	276.77	306.34	291.25	336.29	446.02	525.18
Net Property, Plant & Equipment	1.2	1.3	13.43	16.13	9.98	11.23
Other Intangible Assets	-	-	-	-	14.36	13.58
Long-Term Investments	-	-	-	1.65	31.15	41.24
Other Long-Term Assets	13.53	15.52	17.3	0.71	27.66	26.74
Total Assets	291.5	323.15	321.98	354.78	529.17	617.97
Accounts Payable	5.3	9.18	18.03	15.57	12.35	12.08
Accrued Expenses	57.7	57.99	62.44	52.1	-	3.75
Short-Term Debt	-	-	-	-	-	6.58
Current Portion of Long-Term Debt	4.64	3	-	-	12.47	-
Current Portion of Leases	-	-	-	-	1.1	1.03
Other Current Liabilities	-	-	-	-	73.04	50.5
Total Current Liabilities	67.63	70.16	80.47	67.67	98.96	73.94
Long-Term Debt	111.04	112.45	113.63	112.73	97.24	-
Long-Term Leases	0.99	1.03	8	10.18	6.56	6.99
Other Long-Term Liabilities	328.21	325.34	322.53	312.45	212.35	218.66
Total Long-Term Liabilities	440.25	438.82	444.15	435.36	316.16	225.66
Total Liabilities	507.87	508.98	524.62	503.03	440.44	451.88
Common Stock	11.23	11.08	8.43	7.31	7.31	6.45
Treasury Stock	-0.21	-0.21	-0.22	-0.54	-0.68	-0.13
Additional Paid-in Capital	1,442	1,440	1,284	1,181	1,163	1,084
Accumulated Other Comprehensive Income	-0.8	-0.52	-1.42	-0.09	-0.36	0.18
Retained Earnings	-1,669	-1,636	-1,493	-1,335	-1,081	-924.89
Shareholders' Equity	-216.38	-185.83	-202.64	-148.25	88.73	166.09
Total Liabilities & Equity	291.5	323.15	321.98	354.78	529.17	617.97
Total Debt	116.67	116.49	121.63	122.91	117.38	14.6
Net Cash (Debt)	114.34	144.85	129.24	155.69	209.07	451.95
Net Cash Growth	-21.06%	12.08%	-16.99%	-25.53%	-53.74%	4.59%
Net Cash Per Share	0.82	1.14	1.33	1.91	2.67	5.89
Book Value	-216.38	-185.83	-202.64	-148.25	88.73	166.09
Book Value Per Share	-1.56	-1.46	-2.09	-1.81	1.14	2.16
Tangible Book Value	-216.38	-185.83	-202.64	-148.25	74.37	152.51
Tangible Book Value Per Share	-1.56	-1.46	-2.09	-1.81	0.95	1.99

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q